CONCORD Stock View

Concord Drugs Ltd

CONCORD Stock View

(BSE)

Trade

0.60 | 1.76

Market Cap ₹( Cr.)
346.80

Proj. P/E (x)

Proj. P/BV (x)

Proj. ROE (%)

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)

Last Updated On.
26-Nov-2023

 

Copy Link

Concord Drugs Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of licensed drugs based on the formulations approved. The Company offers finished pharmaceutical formulations, such as injectables (small volume parenteral, dry powders), tissue bio-adhesive, tablets, capsules, liquid orals (syrup & suspension) and dry syrups (powder). The Company also provides ready-to-fill pellets and multiple unit pellets system (MUPS). Its pellets are categorized as gastrointestinal drug pellets, cardiovascular drug pellets, respiratory drug pellets, anti-obesity drug pellets, anti-depressant drug pellets, central nervous system drug pellets, urological drug pellets, anti-microbial, anti-infective and adjuvant drugs pellets, taste mask drug pellets/powder, nutrition and food supplement drug pellets, anti-cholesterol drug pellets. The Company also provides Iso Amyl 2-Cyano Acrylate, which is a bio-adhesive product.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data